baber/WOPTO huggingface dataset:
Patent NZ-541989-A (NZ)
Title: Improved sodar sounding of the lower atmosphere
Inventor: MARTIN ANDREW LOUIS
IPC: G01S15/88
Filed: 2004-02-26
Abstract: A method and system for acoustically sounding the lower atmosphere by transmitting an acoustic chirp and processing of returned echoes and interference using wavelet and matched filter techniques is disclosed. A single transmitter and four receivers may be used, with receivers located equidistant from the transmitter on the cardinal points of the compass. N, S, E, & W inputs are digitized and input to a wavelet filter (50) together with the transmitter chirp signal (R or D) for the attenuation of the direct signal and ambient noise signals. The interference-attenuated signals are then processed in a matched filter (52) to extract phase and amplitude outputs (54 and 56), the phase output being unwrapped (70). The N and S phase signals and the E and W phase signals are then separately differenced (74 and 80) and the results used to compute (86 and 92) wind speed and bearing. Extracted amplitude signals (56) are put through a second wavelet filter (58) to remove echo clutter before being stored, along with the wind speed and bearing data in a range gate (96).
Patent NZ-543044-A (NZ)
Title: Thorium-227 for use in radiotherapy of soft tissue disease
Inventor: LARSEN ROY
IPC: A61K/
Filed: 2004-04-15
Abstract: Disclosed is a method for the treatment of soft tissue disease in a non-human mammalian subject, comprising administering to the subject a therapeutically effective quantity of a soft tissue targeting complex of thorium-227 and a complexing agent wherein: the therapeutically effective quantity is such that an acceptably non-myelotoxic quantity of radium-223 is generated in vivo by nuclear decay of the administered thorium-227, the thorium-227 is conjugated to a targeting moiety with bioaffinity, excluding bone-seekers, liposomes and folate conjugated antibodies or antibody fragments, and the therapeutically effective quantity of thorium-227 is at least 25 kBq/kg.
Patent NZ-543697-A (NZ)
Title: A biostatic coating composition for reduction or prevention of biofilm formation on moist or wet surfaces
Inventor: KRITZLER STEVEN
IPC: A01N31/16
Filed: 2004-05-18
Abstract: Disclosed is a biostatic coating composition comprising a film forming composition which on drying produces an intrinsically hydrophobic film and including a biocidal complex A-B in which A is a phenolic biocide and B is selected from polyvinylpyrrolidone, polyvinylpyrrolidone polymers, polyvinylpyrrolidone copolymers and mixtures thereof, and wherein the biocidal complex A-B is not water soluble. The coating composition for example is selected from acrylic and methacrylic polymer based compositions, acrylic and methacrylic copolymer based compositions, vinyl polymer based compositions, vinyl copolymer based compositions, epoxy resins, epoxy esters, and mixtures thereof. Suitable biocides include complexes of PVP or PVP copolymer with triclosan; diclosan; dichlorophen; orthophenylphenol; orthobenzylparachlorophenol, cresols, xylols, and substituted diphenyl ethers.
Patent NZ-546662-A (NZ)
Title: Composition and dosage form for sustained effect of levodopa
Inventor: FLASHNER-BARAK MOSHE
IPC: A61K31/198
Filed: 2004-10-14
Abstract: Disclosed is a composition comprising a therapeutically effecive amount of levodopa or a metabolic precursor thereof, and methylphenidate in an amount sufficient to decresae dopamine elimination, formulated so that the methylphenidate is released about 2 to 7 hours after the release of the levodopa or precursor begins. Also disclosed is a pharmaceutical dosage comprising a methylphenidate core, an enteric coating layer, and an annular sheath containing the levodopa or precursor. This dosage is described as suitable for treating Parkinson's disease.
Patent NZ-551302-A (NZ)
Title: Encapsulated wood preservatives
Inventor: HAYWARD PETER JAMES
Filed: 2006-11-15
Abstract: Disclosed is the use an organic biocidal composition to treat wood or timber products, such that the composition comprises capsules of a mean particle size of between 1 and 20 microns, with a polymeric outer shell, encapsulating a biocide such as an isothiazolone, a benzthiazole, a pyrethroid, a neonicotenoid, a halogenated carbamate, an azole, a chloronitrile or a combination thereof.
Patent NZ-556476-A (NZ)
Title: Disposable hygiene pants with weld seams reinforced by a non-woven strip containing thermo plastic fibres
Inventor: BACK LUCAS
Filed: 2005-03-02
Abstract: This discloses disposable hygiene pants, such as diaper pants, with a longitudinal direction and a transverse direction, comprising, in the longitudinal direction, a front portion 2, a rear portion 3 and an intermediate crotch portion 4 provided with two leg openings 5 6. The outer longitudinal edge portions 21 22 of the front portion are connected by longitudinal weld seams 7 8 to the outer longitudinal edge portions 31 32 of the rear portion 3 in the transverse direction in order to form a waist opening 9, which is delimited by the outer transverse edge portions 22 33 of the front portion and of the rear portion, and the two leg openings 5 6 in the crotch portion, which leg openings are outwardly delimited in the transverse direction by the inner end portions of the weld seams in the longitudinal direction of the hygiene pants. The hygiene pants have an outer elastic cover 10 and comprise an absorption unit 11 which extends in the longitudinal direction across at least part of the crotch portion 4. The cover which is made of an elastic laminate comprising an elastic film applied between two nonwoven layers, characterized in that the weld seams 7 8 are each reinforced by at least one nonwoven strip 15 16 containing thermoplastic fibres, which nonwoven strip has been applied to the longitudinal edge portions 21 22 and 31 32 of the front portion and rear portion of the hygiene pants at least along the inner end portions, in the longitudinal direction of the hygiene pants, of the two edge portions and has there been welded together with the longitudinal edge portions of the cover in order to form the weld seams 7 8. The tensile strength of the weld seams, in a direction transverse to the weld seam and in the transverse direction, exceeds 5 N/25.4 mm at least in the portions reinforced with the nonwoven strip 15 16, and the breaking strength of the cover in the transverse direction exceeds the tensile strength for the reinforced weld seams.
Patent NZ-562032-A (NZ)
Title: Ocular therapy using glucocorticoid derivatives selectively penetrating posterior segment tissues
Inventor: EDELMAN JEFFREY L
IPC: A61K31/56
Filed: 2006-10-17
Abstract: Disclosed is an ophthalmic composition comprising: a therapeutically effective concentration of Glucocorticoid Derivative (GD), comprising an acyl group linked to C17 via an ester linkage, wherein said GD has a lipophilicity greater than about 4.0, wherein the term lipophilicity relates to log P, and wherein P is the octanol/water partition coefficient. Also disclosed is the use of the composition in the manufacture of a medicament for treating a condition of the posterior segment of a mammalian eye
Patent NZ-568589-A (NZ)
Title: A battery pack suitable for a cordless power tool
Inventor: MURRAY CHRISTOPHER
IPC: H01M50/209
Filed: 2008-05-26
Abstract: A battery pack including a housing, at least one battery cell and first and second terminals is provided. The housing includes a substantially ovoidal surface which is substantially symmetrical about a first axis of symmetry, and a second axis of symmetry which is transverse to the first axis. The surface has first and second substantially linear terminal openings, with the first opening extending substantially parallel to and non-coincidental with the first axis and the second opening extending substantially parallel to the second axis. The battery cells are contained within the housing. The first and second terminals are within the housing adjacent to the surface, with the first terminal accessible through the first opening and the second terminal accessible through the second opening.
Patent NZ-568652-A (NZ)
Title: Commercial process for making forskolin and its derivatives
Inventor: MAJEED MOHAMMED
IPC: A61K31/352
Filed: 2007-02-02
Abstract: Disclosed are processes making isoforskolin consisting of: (a) pulverizing dried Coleus roots; (b) extracting the root powder obtained in step (a) with a solvent selected from a mixture of water and alcohol, Cl-C4 alcohols, methylene dichloride, toluene, or hexane; (c) concentrating the extract obtained in step (b); (d) precipitating the concentrate obtained in step (c) with a non-polar solvent selected from heptane, pentane or hexane; (e) filtering the precipitate obtained in step (d); (f) back extracting the filtrate obtained in step (e) with a mixture of water and alcohol; and (g) crystallizing the isoforskolin in alcohol. Also disclosed is a commercial process for making isoforskolin consisting of: (a) pulverizing dried Coleus roots; (b) extracting the root powder obtained in step (a) with supercritical carbon dioxide and cosolvent ethanol at a temperature of 45° to 55° C and pressure 300 bar; and (c) crystallizing the isoforskolin in ethanol. Optionally the extract from step (b) can be hydrolysed with a lipase enzyme to form 7-deacetylforskolin and crystallizing the 7-deacetylforskolin in ethanol.
Patent NZ-572204-A (NZ)
Title: Process for the preparation of pyrazolylaminoquinazoline derivatives comprising a phosphate group
Inventor: PITTAM JOHN DAVID
IPC: C07F9/02
Filed: 2007-05-14
Abstract: Disclsoed herein is a process for preparing an intermediate compound of formula (IIA), wherein R is an acid labile protecting group such as tert-butyl, trityl, p-methoxyphenyl, benzy or phenyl; which process comprises adjusing the pH of a solution to a compound of formula (IIIA) to pH 5 to 6.5 at a temperature of -10°C to ambient temperature. Also disclosed is a process for the preparation of AZD1152 (formula (IA)), from a compound of formula (IIA) wherein R is tert-butyl; wherein the process comprises the steps of 1) adding a suitable acid to a solution of a compound of formula (IA); and 2) adjusting the pH of the resulting mixture to pH 4.5 to 5.5; and then optionally 3) forming a pharmaceutically acceptable salt of AZD1152.
Patent NZ-572790-A (NZ)
Title: N- (2-thiazolyl) -amide derivatives as gsk-3 inhibitors
Inventor: MARTINEZ GIL ANA
IPC: A61K31/41
Filed: 2007-04-27
Abstract: Disclosed is a compound of formula (I), or a salt or solvate thereof, wherein X is an indol of formula (A) or (B) or an indazol of formula (C), and the other substituents are disclosed within the specification. Also disclosed is the use of the said compound for the manufacture of a medicament for the treatment of a disease or a condition mediated by GSK-3. Also disclosed is a process of preparing the compound of formula (I).
Patent NZ-573557-A (NZ)
Title: High affinity antibodies to human il-6 receptor
Inventor: STEVENS SEAN
IPC: A61K39/00
Filed: 2007-06-01
Abstract: Disclosed is an antibody or antigen-binding fragment thereof, which specifically binds human interleukin-6 receptor (hIL-6R), comprising heavy chain and light chain CDR domains as defined in the specification. The antibody can be used in the treatment of IL-6-mediated diseases or disorders, for example arthritis, inflammatory bowel disease or systemic erythematosus.
Patent NZ-575939-A (NZ)
Title: Phenylpropionamide compounds and the use thereof
Inventor: ZHOU XIAOMING
IPC: A61P29/02
Filed: 2007-10-31
Abstract: Disclosed is a pyridine compound represented by general formula (I) wherein variable A is cycloalkyl, heterocycloalkyl, aryl or heteroaryl and B is (CH2)m. Also disclosed is the use of the compounds of formula (I) for treating pain, diarrhea or emesis.
Patent NZ-581416-A (NZ)
Title: Antibodies useful for therapy and diagnosis of melanoma
Inventor: HUMER JOHANNES
IPC: G01N33/574
Filed: 2008-05-23
Abstract: Disclosed are antibodies, or fragments thereof, for isolating and/or identifying epitopes of an endogenous retrovirus, preferably of a melanoma associated endogenous retrovirus, and hybridoma cells producing said antibodies. The antibodies are useful especially for the treatment and diagnosis of cancer. Further, the present application covers diagnostic kits for the detection of cancer cells, especially of melanoma cells and methods for cancer diagnosis using said antibodies.
Patent NZ-581582-A (NZ)
Title: Method for producing mature vwf from vwf pro-peptide
Inventor: MUNDT WOLFGANG
IPC: C07K14/435
Filed: 2008-05-16
Abstract: Disclosed is a method for producing mature von Willebrand Factor (VWF) from von Willebrand Factor pro-peptide comprising the steps of: (a) Immobilizing VWF pro-peptide on an ion exchange resin; (b) Incubating the immobilized VWF pro-peptide with furin comprising activity of at least 0.2 Units furin/Unit VWF antigen (Ag) to obtain immobilized mature VWF; and (c) Isolating at least 90% mature VWF from the ion exchange resin by elution.
Patent NZ-581945-A (NZ)
Title: Machine direction oriented multilayer film draw tape
Inventor: O'DONNELL HUGH J
IPC: B32B27/32
Filed: 2008-05-21
Abstract: A draw tape (120) for a draw tape bag (100). The draw tape includes a first skin layer (160), a second skin layer (162), and at least one core layer (164) disposed between the skin layers. The draw tape is machine direction oriented. The core layer may include high density polyethylene or medium density polyethylene. The skin layers may include low density polyethylene or linear low density polyethylene. The draw tape bag may include a bag body defining a cavity and a rim (106), the rim defining a mouth to the bag. The bag may include a hem (112) including a passageway (114), the hem defining at least one opening. The bag includes at least one multilayer polyolefin machine direction oriented draw tape disposed within the hem.
Patent NZ-582191-A (NZ)
Title: Heptacyclic compounds and the pharmaceutical uses thereof for preventing and treating diabetes and metabolic syndrome
Inventor: CHEN JUNHUA
IPC: A61K31/55
Filed: 2007-05-29
Abstract: Disclosed herein are dibenzo[b,e][1,4]dioxepine derivatives of formula (I), wherein X is O, R3 is OR', and the other substituents are as defined within the specification, processes for their preparation, compositions comprising said compounds and uses thereof. Said compounds are useful in the treatment of diabetes or a metabolic syndrome such as insulin resistance, hyperinsulinemia, abnormal glucose tolerance, obesity, adiposis, hepatica, hyperuricacidemia, arthrolithiasis, hyperlipedia, hyperchloesteremia, artherosclerosis or hypertension.
Patent NZ-585622-A (NZ)
Title: Hepatitis c virus antibodies
Inventor: MATTHEWS DAVID J
IPC: C07K16/10
Filed: 2008-12-17
Abstract: Disclosed is A humanized antibody that binds hepatitis C virus E2 protein or an antigen binding fragment thereof, wherein the humanized antibody or antigen binding fragment thereof comprises a variable heavy chain domain selected from the group consisting of SEQ ID NO:10, SEQ ID NO:11, SEQ ID NO: 12, SEQ ID NO:13, SEQ ID NO:14, SEQ ID NO:15, SEQ ID NO:16, SEQ ID NO:17, and SEQ ID NO: 18.
Patent NZ-587173-A (NZ)
Title: Method for producing isothiocyanate compound having carboxyl group
Inventor: NAKANO SATOSHI
IPC: C07C331/28
Filed: 2009-02-27
Abstract: Disclosed is a method for producing an isothiocyanate compound which has a carboxyl group(s) and is represented by the formula: (SCN)m-A-B-(CO2H)n Said method comprising reacting an amino compound which has a carboxyl group(s) and is represented by the formula: (H2N)m-A-B-(CO2H)n Wherein the substituents are as described within the specification.
Patent NZ-587328-A (NZ)
Title: Method and apparatus for pressurized calcination of gypsum
Inventor: LUAN WENQI
IPC: C01G29/00
Filed: 2009-02-17
Abstract: Disclosed is a method for calcining gypsum, comprising injecting gypsum into a pressurized reactor; injecting combustion gases and air into the pressurized reactor to create a fluidized bed of gypsum in the reactor; and heating the fluidized bed of gypsum in the pressurized reactor to sufficiently calcine the gypsum to form a calcined hemihydrate; and combusting fuel and air in a burner to create the combustion gases; diverting a portion of the combustion gases to the pressurized reactor to create the fluidized bed; and directing a remaining portion of the combustion gases to a heat exchanger used for heating the fluidized bed.
Patent NZ-587531-A (NZ)
Title: Desulphurisation materials
Inventor: POTTER GAVIN
IPC: B01J23/80
Filed: 2009-02-25
Abstract: Disclosed herein is a particulate desulphurisation material comprising one or more nickel compounds, a zinc oxide support material, one or more copper compounds and one or more alkali metal compounds consisting of an oxide, carbonate or hydrogen carbonate of sodium, lithium, potassium or caesium wherein the nickel content of the material is in the range of 0.3% to 10% by weight, the copper content of the material is in the range 0.3 to 10% by weight and the alkali metal content of the material is in the range 0.2 to 10% by weight.
Patent NZ-587882-A (NZ)
Title: Methods of forming yarn and apparatus for twisting or cabling yarn
Inventor: RITTENHOUSE RONNIE
IPC: D01H9/18
Filed: 2009-03-06
Abstract: Disclosed is a yarn twisting or cabling apparatus and methods of using such. The apparatus includes a bucket having a bucket top and a bucket bottom, a reserve disc, and an adjustable extension arm with a balloon thread guide. The bucket is disposed on the reserve disc so that the bucket bottom is on the reserve disc. The adjustable extension arm is positioned so that the balloon thread guide is positioned above the bucket top along the centre line of the bucket.
Patent NZ-589444-A (NZ)
Title: NON-HORMONAL STEROID MODULATORS OF NF-Kappa B FOR TREATMENT OF DISEASE
Inventor: MCCALL JOHN M
IPC: A61P11/06
Filed: 2009-05-28
Abstract: Disclosed is the use of pregnane steroids such as pregnatrienediones and pregnadienediones in the manufacture of a medicament for the treatment of arthritis. Specific examples of pregnane compounds used include: (10S,13S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,10,12,13,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3(2H)-one, 2-oxo-2-((6S,10R,13S)-6,10,13-trimethyl-3-oxo-6,7,8,10,12,13,14,15-octahydro-3H-cyclopenta[a]phenanthren-17-yl)ethyl acetate, and 2-oxo-2-((10S,13S,16S,17S)-10,13,16-trimethyl-3-oxo-2,3,6,7,8,10,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)ethyl acetate.
Patent NZ-589858-A (NZ)
Title: Process for separating solids from valuable or harmful liquids by vaporisation
Inventor: NAZZER CRAIG
IPC: B01D1/00
Filed: 2009-06-15
Abstract: Disclosed herein is a method of extracting solids, which are dissolved or undissolved, from a mixture of water and a process liquid, comprising the steps of: a) placing an oil or oil-like recycle source liquid that is less dense than water, preferably mono-ethylene glycol, and is comprised of components that are substantially non-miscible with and less volatile than water and less volatile than the process liquid, into a separation vessel; b) introducing a feed stream comprising a mixture of water, the process liquid and the solids to be extracted, into a mixing zone in proximity to or within the separation vessel; c) rapidly boiling or flashing the feed stream upon mixing the feed stream with a recycle fluid in the mixing zone to produce a vapour in proximity to or within the separation vessel; d) separating the vapour from unvaporised components of a mixture of the feed stream and the recycle fluid; e) collecting the unvaporised components in a substantially liquid pool in a lower portion of the separation vessel; f) drawing the recycle fluid from the substantially liquid pool at a rate that is more than ten times the feed stream flow rate; g) pumping the recycle fluid through a heat exchanger; h) supplying sufficient heat to the recycle fluid in the heat exchanger such that the amount of heat added to the recycle fluid is sufficient to vaporise volatile components of the feed stream when the recycle fluid and the feed stream are mixed in the mixing zone; i) allowing at least a portion of the solids in the substantially liquid pool and at least a portion of any liquid bound thereto to move into a stripping zone and come into contact with water contained therein; j) allowing at least a portion of the solids that has moved into the stripping zone to move through at least a portion of the water in the stripping zone; k) wherein the passage of the portion of solids through the portion of the water displaces at least a portion of any other liquid bound to the portion of the solids; and I) removing from the stripping zone a waste aqueous stream comprising at least a portion of the solids that have entered the stripping zone.
Patent NZ-591037-A (NZ)
Title: Wound healing using choroid plexus secreted proteins
Inventor: THANOS CHRISTOPHER
IPC: A61K35/30
Filed: 2009-07-15
Abstract: 591037 Disclosed are methods of improving tissue wound healing comprising the administration of choroid plexus (CP) secreted proteins isolated or purified from CP condition media to a non-human patient in need thereof. Further disclosed are cosmetic method for improving the appearance of skin after superficial skin wounding, treating a wound, promoting wound healing, decreasing accumulation of collagen or fibroblasts at a wound site or improving hair growth by the administering CP secreted proteins isolated or purified from CP conditioned media. Further disclosed is the use of CP secreted proteins isolated or purified from CP conditioned media in the manufacture of a medicament for improving tissue wound healing, treating a wound, promoting wound healing or decreasing accumulation of collagen or fibroblast at a wound site. Further disclosed is the use of CP condition media or encapsulated CP cells in the manufacture of a medicament for improving tissue wound healing.
Patent NZ-591338-A (NZ)
Title: Platelet-derived growth factor compositions and methods for the treatment of tendon and ligament injuries
Inventor: LYNCH SAMUEL E
IPC: A61L27/24
Filed: 2009-09-09
Abstract: Patent No. 591338 Disclosed is the use of a composition comprising: a biocompatible matrix and platelet-derived growth factor (PDGF) in the manufacture of a medicament for the treatment of a ligament injury not involving a bone, wherein the biocompatible matrix comprises collagen, wherein the biocompatible matrix comprises pores, wherein the biocompatible matrix has a porosity of at least about 80%, and wherein the composition is capable of releasing at least about 50% of the PDGF within about 24 hours.
Patent NZ-596906-A (NZ)
Title: Pepper hybrid ps09967422
Inventor: MCCARTHY WILLIAM
IPC: A01H5/08
Filed: 2011-12-06
Abstract: Provided is a pepper plant, comprising at least a first set of the chromosomes of pepper line SMO 28-1284, a sample of seed of said line having been deposited under ATCC Accession Number PTA-10077. Further provided is the pepper hybrid PS09967422, a sample of seed of said hybrid PS09967422 having been deposited under ATCC Accession Number PTA-11511. Also provided are methods of using the lines in pepper breeding.
Patent NZ-597992-A (NZ)
Title: Heat resistant probiotic compositions and healthy food comprising them
Inventor: PENHASI ADEL
IPC: A23L35/00
Filed: 2010-07-08
Abstract: NZ 597992 Disclosed is a probiotic granule comprising: a core comprising probiotic microorganisms comprising at least one strain selected from the group consisting of Lactobacillus, Bifidobacterium, Bacillus, Escherichia, Streptococcus, Diacetylactis, and Saccharomyces, or a combination thereof; an inner layer of vegetable oil coating said core; and a first outer layer and a second outer layer, which outer layers coat said core and said inner layer, comprising at least two different polymers as defined in the complete specification.